Open Access

[Corrigendum] Inhibition of P‑glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension

  • Authors:
    • Xiao-Yu Sun
    • Zhi-Jun Duan
    • Zhen Liu
    • Shun-Xiong Tang
    • Yang Li
    • Shou-Cheng He
    • Qiu-Ming Wang
    • Qing-Yong Chang
  • View Affiliations

  • Published online on: March 28, 2022     https://doi.org/10.3892/etm.2022.11281
  • Article Number: 354
  • Copyright : © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Exp Ther Med 12:[Related article:] 3716–3722, 2016; DOI: 10.3892/etm.2016.3808

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that Fig. 2 on p. 3720 contained an apparent error: Namely, the ‘CYP3A4’ and ‘MRP2’ data panels for Group N in Fig. 2C appeared to be overlapping, such that they were derived from the same original source.

The authors have re-examined their original data, and have realized that this figure was inadvertently assembled incorrectly owing to the similarity of the data shown in the two affected panels. The revised version of Fig. 2 is shown on the next page, now including the correct data for the ‘MRP2’ data panel in Fig. 2C. Note that this error did not have a major impact on either the overall results or on the conclusions reported in this study. The authors are grateful to the Editor of Experimental and Therapeutic Medicine for allowing them the opportunity to publish this corrigendum. All the authors agree to the publication of this corrigendum, and apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

May-2022
Volume 23 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun X, Duan Z, Liu Z, Tang S, Li Y, He S, Wang Q and Chang Q: [Corrigendum] Inhibition of P‑glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension. Exp Ther Med 23: 354, 2022.
APA
Sun, X., Duan, Z., Liu, Z., Tang, S., Li, Y., He, S. ... Chang, Q. (2022). [Corrigendum] Inhibition of P‑glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension. Experimental and Therapeutic Medicine, 23, 354. https://doi.org/10.3892/etm.2022.11281
MLA
Sun, X., Duan, Z., Liu, Z., Tang, S., Li, Y., He, S., Wang, Q., Chang, Q."[Corrigendum] Inhibition of P‑glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension". Experimental and Therapeutic Medicine 23.5 (2022): 354.
Chicago
Sun, X., Duan, Z., Liu, Z., Tang, S., Li, Y., He, S., Wang, Q., Chang, Q."[Corrigendum] Inhibition of P‑glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension". Experimental and Therapeutic Medicine 23, no. 5 (2022): 354. https://doi.org/10.3892/etm.2022.11281